MX369967B - Tableta recubierta enterica. - Google Patents
Tableta recubierta enterica.Info
- Publication number
- MX369967B MX369967B MX2015010871A MX2015010871A MX369967B MX 369967 B MX369967 B MX 369967B MX 2015010871 A MX2015010871 A MX 2015010871A MX 2015010871 A MX2015010871 A MX 2015010871A MX 369967 B MX369967 B MX 369967B
- Authority
- MX
- Mexico
- Prior art keywords
- coating film
- coated tablet
- enteric coated
- enteric
- tablet
- Prior art date
Links
- 239000002662 enteric coated tablet Substances 0.000 title abstract 4
- 239000011248 coating agent Substances 0.000 abstract 6
- 238000000576 coating method Methods 0.000 abstract 6
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000002702 enteric coating Substances 0.000 abstract 2
- 238000009505 enteric coating Methods 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- 229920003169 water-soluble polymer Polymers 0.000 abstract 2
- 238000005303 weighing Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Para proporcionar una tableta recubierta entérica que contiene una gran cantidad de ingrediente medicinal y que tiene suficiente resistencia al impacto, sin formar una capa de recubrimiento entérico gruesa; la tableta recubierta entérica, contiene (A) una tableta con núcleo que contiene un ingrediente medicinal y que tiene un peso de 1,000 mg o más; (B) una capa de recubrimiento que contiene un polímero soluble en agua aplicado en la superficie de la tableta con núcleo; y (C) una capa de recubrimiento entérica que se disuelve a un pH de 7 o más alto que se aplica en la superficie de la capa de recubrimiento que contiene un polímero soluble en agua, en donde la suma de la cantidad de polímero de la capa de recubrimiento (B) y la cantidad de polímero de la capa de recubrimiento (C) es 10 a 18 mg/cm2, la cantidad de polímero de la capa de recubrimiento (8) es 6 a 12 mg/cm2, y la cantidad de polímero de la capa de recubrimiento (C) es 3 a 6 mg/cm2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013032759 | 2013-02-22 | ||
PCT/JP2014/054104 WO2014129568A1 (ja) | 2013-02-22 | 2014-02-21 | 腸溶錠 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015010871A MX2015010871A (es) | 2015-12-01 |
MX369967B true MX369967B (es) | 2019-11-27 |
Family
ID=51391349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015010871A MX369967B (es) | 2013-02-22 | 2014-02-21 | Tableta recubierta enterica. |
Country Status (25)
Country | Link |
---|---|
US (4) | US20150374632A1 (es) |
EP (1) | EP2959892B1 (es) |
JP (1) | JP6237760B2 (es) |
KR (1) | KR102167265B1 (es) |
CN (1) | CN105025888B (es) |
AU (1) | AU2014219726B2 (es) |
BR (1) | BR112015020237B1 (es) |
CA (1) | CA2901166C (es) |
CY (1) | CY1123908T1 (es) |
DK (1) | DK2959892T3 (es) |
ES (1) | ES2821766T3 (es) |
HR (1) | HRP20201808T1 (es) |
HU (1) | HUE052167T2 (es) |
IL (1) | IL240575B (es) |
LT (1) | LT2959892T (es) |
MX (1) | MX369967B (es) |
NZ (1) | NZ711201A (es) |
PT (1) | PT2959892T (es) |
RS (1) | RS61099B1 (es) |
RU (1) | RU2675844C2 (es) |
SG (1) | SG11201506653WA (es) |
SI (1) | SI2959892T1 (es) |
TW (1) | TWI688411B (es) |
WO (1) | WO2014129568A1 (es) |
ZA (1) | ZA201506585B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2990578C (en) | 2015-06-30 | 2023-09-26 | National University Corporation Okayama University | Drug for preventing or treating inflammatory bowel disease |
EP3162362A1 (de) * | 2015-10-30 | 2017-05-03 | Dr. Falk Pharma Gmbh | Optimierte mesalazinhaltige hochdosistablette |
CN106511277A (zh) * | 2016-11-22 | 2017-03-22 | 吉林省博大伟业制药有限公司 | 一种聚普瑞锌颗粒剂及其制备方法 |
US10098898B1 (en) | 2017-12-04 | 2018-10-16 | Handa Pharmaceuticals, Llc | Release stable mesalamine dosage forms |
EP3662898A1 (en) * | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Solid composition comprising mesalazine |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58109413A (ja) * | 1981-12-23 | 1983-06-29 | Eisai Co Ltd | 耐衝撃性腸溶錠 |
US5914132A (en) | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
ITMI991316A1 (it) * | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
US20020028240A1 (en) * | 2000-04-17 | 2002-03-07 | Toyohiro Sawada | Timed-release compression-coated solid composition for oral administration |
BRPI0117180B8 (pt) | 2001-11-23 | 2021-05-25 | Procter & Gamble | composição farmacêutica em uma forma de unidade sólida de dosagem para a administração oral a um ser humano ou animal inferior |
CA2514879C (en) * | 2003-01-03 | 2014-09-16 | Shire Laboratories Inc. | Two or more enteric materials to regulate drug release |
RU2375048C2 (ru) * | 2003-07-17 | 2009-12-10 | Д-Р Редди'С Лабораторис Инк. | Фармацевтическая композиция с набухающим покрытием |
MY147202A (en) | 2003-11-26 | 2012-11-14 | Novartis Ag | Compositions comprising organic compounds |
DE102006035549A1 (de) * | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
WO2008135090A1 (en) * | 2007-05-07 | 2008-11-13 | Evonik Röhm Gmbh | Solid dosage forms comprising an enteric coating with accelerated drug release |
JP2011500553A (ja) * | 2007-10-10 | 2011-01-06 | ルピン・リミテッド | 5−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤 |
US20090162434A1 (en) | 2007-12-21 | 2009-06-25 | Disphar International Bv | Mesalazine tablet |
US8329208B2 (en) * | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
CN101732280B (zh) * | 2009-10-23 | 2012-04-18 | 天津力生制药股份有限公司 | 一种结肠定位释药的口服制剂 |
EP2425826A1 (en) | 2010-09-01 | 2012-03-07 | Disphar International B.V. | Mesalazine tablet having improved dissolution |
EP2468264A1 (en) * | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
ES2655622T3 (es) * | 2012-04-30 | 2018-02-20 | Tillotts Pharma Ag | Una formulación de fármaco de liberación retardada |
-
2014
- 2014-02-21 US US14/769,660 patent/US20150374632A1/en not_active Abandoned
- 2014-02-21 AU AU2014219726A patent/AU2014219726B2/en active Active
- 2014-02-21 WO PCT/JP2014/054104 patent/WO2014129568A1/ja active Application Filing
- 2014-02-21 HU HUE14754975A patent/HUE052167T2/hu unknown
- 2014-02-21 SG SG11201506653WA patent/SG11201506653WA/en unknown
- 2014-02-21 CA CA2901166A patent/CA2901166C/en active Active
- 2014-02-21 NZ NZ71120114A patent/NZ711201A/en unknown
- 2014-02-21 SI SI201431710T patent/SI2959892T1/sl unknown
- 2014-02-21 KR KR1020157022571A patent/KR102167265B1/ko active IP Right Grant
- 2014-02-21 BR BR112015020237-3A patent/BR112015020237B1/pt not_active IP Right Cessation
- 2014-02-21 JP JP2015501510A patent/JP6237760B2/ja active Active
- 2014-02-21 ES ES14754975T patent/ES2821766T3/es active Active
- 2014-02-21 MX MX2015010871A patent/MX369967B/es active IP Right Grant
- 2014-02-21 LT LTEP14754975.2T patent/LT2959892T/lt unknown
- 2014-02-21 PT PT147549752T patent/PT2959892T/pt unknown
- 2014-02-21 CN CN201480009951.3A patent/CN105025888B/zh active Active
- 2014-02-21 EP EP14754975.2A patent/EP2959892B1/en active Active
- 2014-02-21 RU RU2015140119A patent/RU2675844C2/ru active
- 2014-02-21 DK DK14754975.2T patent/DK2959892T3/da active
- 2014-02-21 RS RS20201388A patent/RS61099B1/sr unknown
- 2014-02-21 TW TW103105940A patent/TWI688411B/zh active
-
2015
- 2015-08-13 IL IL240575A patent/IL240575B/en active IP Right Grant
- 2015-09-07 ZA ZA2015/06585A patent/ZA201506585B/en unknown
-
2018
- 2018-09-20 US US16/136,377 patent/US20190015345A1/en not_active Abandoned
-
2020
- 2020-11-12 HR HRP20201808TT patent/HRP20201808T1/hr unknown
- 2020-12-08 CY CY20201101162T patent/CY1123908T1/el unknown
- 2020-12-11 US US17/118,824 patent/US20210093577A1/en not_active Abandoned
-
2023
- 2023-08-01 US US18/363,001 patent/US20230372250A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ711201A (en) | Enteric coated tablet | |
AU2018223054B2 (en) | Asymmetric multilayer film for ostomy application | |
SG10201908380TA (en) | Treatment of fibrosis | |
GB2556269A (en) | Fibrosis model on a chip | |
CA140754S (en) | Tablet | |
SG10201811146PA (en) | Water soluble pouch comprising an embossed area | |
EP4233889A3 (en) | Activin-actrii antagonists and uses for treating myelodysplastic syndrome | |
AU201616181S (en) | Communication Device | |
MX2016005482A (es) | Formas de dosificacion granuladas disuasivas del abuso de liberacion inmediata. | |
MX2015009104A (es) | Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares. | |
JO3343B1 (ar) | أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها | |
AU335305S (en) | Packaging container with surface ornamentation | |
AU367628S (en) | Exercise equipment | |
MX2015010083A (es) | Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos. | |
AU361734S (en) | Dietary supplement packaging with indicium | |
SG196814A1 (en) | Coating and developing apparatus | |
WO2014114255A3 (zh) | 一种定位速释生物粘附剂及应用 | |
MX2021014922A (es) | Capsulas de gel blando de liberacion retardada. | |
AU361681S (en) | Dietary supplement packaging with indicium | |
AU2015352158A8 (en) | Medicaments for slowing Parkinson's Disease | |
EP2966570A3 (en) | Proximity-based inter-computing device negotiation | |
MX2012010229A (es) | Forma de dosis de liberacion modificada. | |
AU356947S (en) | Package for ostomy barrier ring | |
CA139078S (en) | Carrying case | |
MX2015012074A (es) | Composicion farmaceutica de mesalamina con multiples elementos de dosis para viabilidad de administracion reducida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |